Earnings
URGN
22.57
+7.27%
1.53
Currencies: USD
Items
Total Revenue
Revenue
Cost of Revenue
Gross Profit
Marketing and Administrative Expenses
Research and Development Costs
Financial Expenses
Depreciation and Amortization
Other Expenses
Total Operating Expenses
Asset Impairments
Operating Income
Interest Income
Assets Disposal
Other Non-operating Net Income
Non-operating Income
Net Income Before Taxes
Provision for Income Taxes
Net Income
Minority Interests
Net Income Attributable to Shareholders
Net Income Attributable to Common Equities
Net Income from Discontinued Operations
Basic EPS
Diluted EPS
FY 2019-12-31
18.00K
18.00K
0.00
18.00K
60.20M
49.30M
--
--
--
109.50M
--
-109.48M
4.62M
--
-284.00K
4.62M
-105.15M
0.00
-105.15M
--
-105.15M
-105.15M
--
--
-5.12
FY 2018-12-31
1.13M
1.13M
1.80M
-675.00K
39.57M
36.93M
--
--
--
78.31M
--
-77.18M
1.77M
--
-124.00K
1.77M
-75.53M
125.00K
-75.66M
--
-75.66M
-75.66M
--
--
-4.80
FY 2017-12-31
8.16M
8.16M
600.00K
7.56M
8.81M
18.70M
--
--
--
28.11M
--
-19.95M
-31.00K
--
--
-31.00K
-19.98M
19.00K
-20.00M
--
-20.00M
-20.82M
--
--
-2.14
FY 2016-12-31
17.53M
17.53M
28.00K
17.50M
6.42M
10.29M
--
--
--
16.73M
--
798.00K
-2.74M
--
--
-2.74M
-1.94M
--
-1.94M
--
-1.94M
-4.41M
--
--
-0.40
FY 2015-12-31
0.00
0.00
0.00
0.00
1.90M
10.52M
--
--
--
12.41M
--
-12.41M
-279.00K
--
--
-279.00K
-12.69M
--
-12.69M
--
-12.69M
-13.54M
--
--
-1.24

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out URGN latest quarterly and annual financial reports. There are also past financial reports for you to reference. You can analyze Urogen Pharma recent business situations from balance sheets, income statements, cash flow statements and other tables. This information may help you make smarter investment decisions.